Cyprus Mail
Business Cyprus Business News International

Covid-19 severe or mild case? Portuguese researchers have discovered why?

t cell
Human T-Cell

The Institute for Research and Innovation in Health (i3S) at the University of Porto announced on Wednesday it has discovered the mechanism that defines why the severity of COVID-19 is so variable in each infected person.

According to an official statement from i3S, a change in T lymphocytes explains “why SARS-CoV-2 infection causes mild or even asymptomatic disease in some individuals and severe and complicated disease in others.”

The study, led by researcher Salome Pinho, showed that circulating T cells “provide protection against the virus” by “exchanging their glycans (sugar molecules) in a specific way after infection with SARS-CoV-2.”

According to the study, there is a more intense “immunological response” in patients with more “glycosylated T lymphocytes,” making them asymptomatic.

Pinho explained that this reaction “can be detected at diagnosis,” and therefore constitutes a “new biomarker of COVID-19 prognosis and severity, as well as a new therapeutic target.”

The research team also demonstrated that, in asymptomatic patients, blood mononuclear cells exhibit an “increased expression of a specific protein,” capable of efficiently recognizing the virus.

Glycosylation is an important post-translational modification, giving rise to a diverse and abundant repertoire of glycans on the cell surface, collectively known as the glycome. When focusing on immunity, glycans are indispensable in virtually all signaling and cell-cell interactions.

More specifically, glycans have been shown to regulate key pathophysiological steps within T cell biology such as T cell development, thymocyte selection, T cell activity and signaling as well as T cell differentiation and proliferation. They are of major importance in determining the interaction of human T cells with tumor cells, according to journal research.

i3S collaborated on this research with the University Hospital Center of Porto, and the Hospital Center of Vila Nova de Gaia/Espinho.

The results of the study, which was funded by the Foundation for Science and Technology (FCT) Research 4 Covid initiative, were published in The Journal of Immunology.

Related posts

Paphos extends campaign to attract more domestic tourism

Paul Lambis

Nigeria to lift Twitter ban ‘very soon’

Reuters News Service

Budget deficit for next three years

Staff Reporter

Cinema chain will accept other cryptocurrencies along with Bitcoin

Reuters News Service

Britain’s Sainsbury’s makes it personal in price battle with rivals

Reuters News Service

NatWest chair sees digital pound piloted within five years

Reuters News Service